The estimated Net Worth of Thomas D. Carey is at least $7.81 Milión dollars as of 2 June 2021. Mr. Carey owns over 17,000 units of Exact Sciences stock worth over $339,323 and over the last 12 years he sold EXAS stock worth over $7,150,002. In addition, he makes $319,023 as Independent Director at Exact Sciences.
Thomas has made over 7 trades of the Exact Sciences stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 17,000 units of EXAS stock worth $1,837,870 on 2 June 2021.
The largest trade he's ever made was selling 30,620 units of Exact Sciences stock on 31 July 2020 worth over $2,878,280. On average, Thomas trades about 4,416 units every 77 days since 2013. As of 2 June 2021 he still owns at least 5,292 units of Exact Sciences stock.
You can see the complete history of Mr. Carey stock trades at the bottom of the page.
Thomas D. Carey serves as Independent Director of the Company. Mr. Carey has served as a director since April 2013. Mr. Carey is the founder and Managing Director of Perspective Group, LLC, a human capital and executive search firm serving the healthcare industry. Previously, Mr. Carey was a member at Spencer Stuart, a global executive search firm, from 2010 through 2015, where he was responsible for leading the firm's global efforts in providing board services to companies within all segments of the healthcare market. Prior to Spencer Stuart, Mr. Carey was with Russell Reynolds Associates from 2001 to 2010 where he served as a Partner and Co-Head of the firm's Global Life Sciences Practice for the three years preceding his move to Spencer Stuart. Prior to entering the search industry, Mr. Carey served as an investment banker and then chief financial officer of both private and public healthcare and information technology companies. Mr. Carey earned a bachelor's degree from the College of the Holy Cross and an MBA from the Kellogg Graduate School of Management at Northwestern University.
As the Independent Director of Exact Sciences, the total compensation of Thomas Carey at Exact Sciences is $319,023. There are 22 executives at Exact Sciences getting paid more, with Kevin Conroy having the highest compensation of $18,716,500.
Thomas Carey is 58, he's been the Independent Director of Exact Sciences since 2013. There are 9 older and 16 younger executives at Exact Sciences. The oldest executive at Exact Sciences Corp. is James Doyle, 74, who is the Independent Director.
Thomas's mailing address filed with the SEC is C/O EXACT SCIENCES CORP., 5505 ENDEAVOR LANE, MADISON, WI, 53719.
Over the last 21 years, insiders at Exact Sciences have traded over $118,141,352 worth of Exact Sciences stock and bought 191,930 units worth $1,451,887 . The most active insiders traders include Kevin T Conroy, Edwin M Jr Kania a Maneesh Arora. On average, Exact Sciences executives and independent directors trade stock every 12 days with the average trade being worth of $1,667,056. The most recent stock trade was executed by Brian Baranick on 5 August 2024, trading 2,712 units of EXAS stock currently worth $173,893.
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences' noninvasive colon cancer screening test, visit cologuardtest.com
Exact Sciences executives and other stock owners filed with the SEC include: